Christie APS

“Our team recognizes the great value that Christie’s 3LCD laser projectors and large format displays can bring to end users in Malaysia, Singapore and Thailand.”

KUALA LUMPUR, Malaysia (PRWEB)
September 10, 2019

Christie® is pleased to announce that Acoustic & Lighting System (A&L) has been appointed the distributor of its 3LCD projectors and large format Secure Series LCD panels for the Malaysia, Singapore and Thailand markets.

Headquartered in Malaysia with nine physical premises catering to diversified markets, A&L has established itself as an industry leader in the distribution of professional sound, lighting and accessories solutions since its inception in 1994. With a well-trained and professional team comprising more than 200 employees stationed in four countries, the company is well-positioned to represent Christie in the distribution marketplace.

“We are excited about our partnership with Christie, which is known for high quality, innovative, and reliable visual solutions that have a track record of pushing technological boundaries,” said Eugene Yeo, General Manager, A&L. “Our team recognizes the great value that Christie’s 3LCD laser projectors and large format displays can bring to end users in Malaysia, Singapore and Thailand. We look forward to working closely with the Christie team to build a long and fruitful business relationship.”

A&L will offer the full range of Christie’s high-performance, powerful and affordable projection solutions comprising the laser-illuminated DS Series and APS Series.

A&L will offer Christie’s powerful and affordable APS (above) and DS series 3LCD laser projectors.

Michael Bosworth, Executive Director, Head of Enterprise for Asia Pacific, Christie, commented, “We are delighted to enter into a partnership with A&L, a respected player boasting over two decades of experience and a solid reputation of being one of the most reliable distributors of today’s most sought-after brands for lighting and sound equipment. The appointment of A&L as our distributor for 3LCD laser projectors and large format displays underscores our strong commitment to customers in Malaysia, Singapore and Thailand.”

The new association represents a seamless match between Christie’s visual solutions and the A&L’s specialty and expertise, which includes maintenance, installation, equipment testing, sales support and after-sales service of audio visual equipment.

For large format displays, A&L will carry Christie’s high-value Secure Series LCD panels

A&L will also carry Christie’s Secure series LCD panels.

A&L will offer the full range of Christie’s high-performance, powerful and affordable 3LCD projection solutions comprising the laser-illuminated ​DS Series and APS Series. For large format displays, A&L will carry Christie’s high-value Secure Series LCD panels ranging from 55 to 98-inch, designed specifically for secure-facility applications typically found in government, corporate and military environments. These include the TAA-compliant, non-RF Christie SUHD551-L, SUHD651-L, SUHD751-P, and SUHD861-P, as well as the upcoming 98-inch LCD display.

About Acoustic & Lighting System

A household brand name in the distribution of professional sound, lighting and accessories solutions, Acoustic & Lighting System (A&L) is an industry leader as well as a respected player with over two decades of experience. A&L has gained the reputation of being one of the most reliable distributors of today’s most sought-after brands for lighting, video and sound equipment. With strong corporate direction and precise positioning in the market, the company continues to expand its footprint as one of the key players in the Southeast Asian region. For more information, visit http://www.acousticlighting.com.

About Christie®

Christie Digital Systems USA, Inc. is a global visual and audio technologies company and a wholly owned subsidiary of Ushio Inc., Japan (JP: 6925). Christie revolutionized the movie industry with the launch of digital cinema projection, and since 1929 has embraced innovation and broken many technology barriers. From the world’s largest mega-events to the smallest applications, our technology—from advanced RGB pure laser and SDVoE technology to image processing and LED display solutions—empowers people to create the world’s best shared experiences. Visit http://www.christiedigital.com.

Share article on social media or email:

MERISTEM, located outside of Sacramento, helps transition young adults on the autism spectrum to independent living, including college and career success.

“Meristem has recorded tremendous growth in its first five years of operation, and we look forward to watching more families benefit from the program’s innovative approach to education, training and empowerment.”

SACRAMENTO, Calif. (PRWEB)
September 10, 2019

The Kelly Foundation awarded its 2019 Major Gift of $100,000 to MERISTEM, a non-profit program that uses experiential learning to help young adults on the autism spectrum become more socially and economically independent. The award constituted the Kelly Foundation’s largest single donation of the year and will be used to expand Meristem’s successful theater program, “Speak Up, Speak Out,” which uses improvisational performance techniques to empower students to participate in spontaneous conversation and a variety of social interactions. Funds from the grant will also be dedicated to the development of a series of parent education events, as well as bolstering Meristem’s independent living curriculum, which includes skill-building in financial literacy, cooking, cleaning and other pursuits.

“The Kelly Foundation is pleased to award this year’s Major Gift to Meristem as an investment in the expansion of its promising curriculum, which equips young adults on the autism spectrum with the skills to lead more independent lives,” said Shawn Kelly Devlin, President of the Kelly Foundation and Chairman of the Board of River City Bank. “Meristem has recorded tremendous growth in its first five years of operation, and we look forward to watching more families benefit from the program’s innovative approach to education, training and empowerment.”

TWEET THIS: The Kelly Foundation, in partnership with @RiverCityBank, awards its 2019 Major Gift of $100,000 to #Sacramento based @goMeristem a three-year program that equips young adults on the autism spectrum with skills for social and economic independence.

“Our staff was in the midst of a training session when we received the call from the Kelly Foundation, and we were over the moon when it became clear that we’d secured the grant,” said Edmund Knighton, President of Meristem. “Our students and their families have always been our top priority, and we’re excited to leverage these funds to expand our parent education and support services, which will keep parents apprised of their student’s progress while also connecting parents with one another in community. We’ll also use some of the grant monies to enhance our improvisational theater program, which helps students develop their spontaneous speaking skills and is our most popular course.”

Knighton says the grant will be used for a variety of building improvements for Meristem’s theater program, including the addition of curtains and backdrops for the stage. Meristem’s staff also intends to bring performer Mickey Rowe, who was the first actor on the autistic spectrum to play an autistic role, back to the school to speak with students and parents about making a living and supporting a family. Rowe was the guest speaker at Meristem’s graduation ceremony in 2019, where he praised the theater program for its incorporation of improvisational techniques and for encouraging students to lead parts of the program. Within the theater program and other areas of the Meristem curricula, students have the opportunity to advance to positions of leadership and mentorship over time, sometimes to the point of leading full segments or even full classes.

The Meristem Method is based upon the principle of “doing to learn” (experiential learning). The five core areas of the curriculum are movement, land work, craftwork, independent living skills, and preparation to work, all accessed by real life experience. Students develop capacities and executive functioning through planning and executing tasks. Students may also apply their training in one of three social enterprises: the Meristem Model Bed and Breakfast, which is the only bed and breakfast in the country operated by young adults on the autism spectrum; the Meristem Herbal Products Company, which provides training in product creation, pricing, sales, packaging and shipping, marketing, website development, ecommerce and business reporting; and the Meristem Café and Bakery, which supplies an assortment of baked goods to the on-campus café and several offsite local businesses.

The Kelly Foundation supports health and human services, education, culture, environment and civic improvement through its funding. Each year, the Foundation provides approximately $400,000 in grants to organizations that support the Sacramento region. Since merging with the RCB Foundation in 2009, the Kelly Foundation, of which River City Bank remains a major contributor, focuses on giving back to the greater Sacramento region through charitable donations.

For more information about the Kelly Foundation, please visit KellyFoundationSacramento.org. For more information about Meristem, visit Meristem.pro.

About the Kelly Foundation

The Kelly Broadcasting Company’s KCRA-TV (Sacramento-Stockton-Modest, CA) went on the air on Sept. 5, 1955, and the owners of the Kelly Broadcasting Company established the Kelly Foundation in December 1988 as a formal vehicle for structuring charitable contributions. The Kelly family sold KCRA-TV in 1999 and have continued the Kelly Foundation ever since. In 2009, the River City Bank Foundation merged with the Kelly Foundation, and some executives of the Bank currently serve on the Foundation’s Board. Jon S. Kelly founded River City Bank and continues to support the Bank. His daughter, Shawn Kelly Devlin, currently serves as President and Chairman of the Board. The Kelly Foundation is an expression of the importance the Kelly family places on being a good neighbor and citizen in regions where they do business. For more information on the Kelly Foundation, please visit KellyFoundationSacramento.org or call (916) 978-4892.

About Meristem

MERISTEM, located outside of Sacramento, helps transition young adults on the autism spectrum to independent living, including college and career success. The Meristem Method uses experiential learning, and all coursework and activities incorporate hands-on, real-world experiences. Learn more at meristem.pro.

About River City Bank

Named one of Sacramento Business Journal’s “50 Fastest Growing Companies” for each of the past three years, River City Bank is the Sacramento region’s premier business bank with assets over $2.4 billion. River City Bank offers a comprehensive suite of banking services, including loans, deposits and cash management tools to the business, consumer and commercial real estate sectors. With tailored, executive-level service and a “Superior” financial rating from the nation’s leading independent bank-rating firm, Bauer Financial, River City Bank redefines the banking experience and every touch point that surrounds it. River City Bank is the largest, independent, locally-owned bank in the Sacramento region with offices in the San Francisco Bay Area and a presence in Southern California. For additional information, please visit RiverCityBank.com or call (916) 567-2600. Member FDIC. Equal Housing Lender.

Share article on social media or email:

The Washington Hilton will be the site for the 2020 FSHD Connect and International Research Congress.

“Our conferences serve vital roles to ensure that all of our stakeholders are working together…to speed up the delivery of effective treatments to our families.” – Mark Stone, CEO

LEXINGTON, Mass. (PRWEB)
September 10, 2019

The FSHD Society announced today that its 27th annual International Research Congress (IRC) will be held on June 25-26, 2020, at the Washington Hilton in Washington, DC. It will be followed on June 27-28 by FSHD Connect, the Society’s biennial global conference bringing together patients, family members, researchers and clinicians for two days of education, advocacy, and networking.

The Society is a patient-focused nonprofit organization that is accelerating the development of treatments for facioscapulohumeral muscular dystrophy (FSHD), a rare, genetic muscle-weakening condition that affects an estimated one million men, women, and children worldwide.

The IRC is the premier global platform for the discussion and dissemination of state-of-the-art research on FSHD. Researchers who have networked at this yearly gathering since 1994 have helped to drive fundamental discoveries, with a broad consensus on a “central hypothesis” of the genetic basis of FSHD, development of cellular and animal models, identification of therapeutic targets, and a proliferation of ideas for treating FSHD.

The biennial FSHD Connect is the world’s largest gathering of patients and families living with FSHD. Leading experts in FSHD clinical care, research, and drug development will share the latest knowledge and answer questions from attendees. There will be workshops to address a wide variety of patient and caregiver concerns. A much-anticipated highlight will be updates from biopharmaceutical companies that are conducting FSHD clinical trials.

“The FSHD International Research Congress and FSHD Connect serve vital roles to ensure that all of our stakeholders are working together, speaking with one voice, to speed up the delivery of effective treatments to our families,” said Mark Stone, President and CEO of the FSHD Society.

About the FSHD Society

The FSHD Society is the world’s largest research-focused patient organization for facioscapulohumeral muscular dystrophy (FSHD), one of the most prevalent forms of muscular dystrophy. The Society has catalyzed major advancements and is accelerating the development of treatments and a cure to end the pain, disability, and suffering endured by one million people worldwide who live with FSHD. The FSHD Society has transformed the landscape for FSHD research and is committed to making sure that no one faces this disease alone. The Society offers a community of support, news, and information through its website at https://www.fshsociety.org.

Share article on social media or email:

These treatments have been shown to be highly effective for some patients and have revolutionized oncology. However, many patients do not respond to immunotherapy, and it is critical to understand why.

RAMAT GAN, Israel (PRWEB)
September 10, 2019

Researchers at Sheba Medical Center, Tel HaShomer and Tel Aviv University (TAU) have discovered why 60% of patients with metastatic melanoma – skin cancer that has spread to other parts of the body – do not respond to immunotherapy. Immunotherapy treatments use the body’s own immune system to control and eradicate cancer.

Melanoma is the most dangerous type of skin cancer. More than 7,000 people will die from melanoma this year in the United States.

The study was conducted by a team of researchers led by Prof. Tami Geiger, Dr. Michal Harel and Prof. Gal Markel of TAU’s Sackler School of Medicine and Sheba’s Ella Lemelbaum Institute for Immuno-Oncology.

“In recent years, a variety of cancer immunotherapy therapies have been used, therapies that strengthen the anti-cancer activity of the immune system,” explained Prof. Gal Markel, a senior oncologist and scientific director of the Ella Lemelbaum Institute at Sheba Medical Center, Tel HaShomer.

“These treatments have been shown to be highly effective for some patients and have revolutionized oncology. However, many patients do not respond to immunotherapy, and it is critical to understand why,” added Markel.”

The scientists examined tumors taken from 116 patients using proteomics. In this new approach, also called “protein mapping,” researchers mapped thousands of proteins. They found differences in the metabolism, or energy production process, of the cancer cells in patients who responded to immunotherapy and those who did not.

In the study published in Cell earlier this month, researchers reported that the non-responding patients tended to have lower fatty acid metabolism, meaning that their enzymes broke down fat for energy at a slower rate.

“In our study, we identified a significant difference between melanoma patients who live years thanks to immunotherapy, and patients who are not at all affected by the treatment,” said Prof. Geiger, head of Tel Aviv University’s Proteomics Lab.

Due to these findings, oncologists now know to check the levels of fatty acid metabolism in their melanoma patients and advise those who have high levels to pursue immunotherapy. Researchers say it may also be possible to raise the levels of fatty acid metabolism in cancer cells with medication to make more patients receptive to immunotherapies. A follow-up study will focus on that area.

Sheba’s Prof Gal Markel is available for interviews on this key discovery and how it could change the treatment options for melanoma patients.

About Sheba Medical Center, Tel HaShomer

Born together with Israel in 1948, Sheba Medical Center, Tel HaShomer is the largest and most comprehensive medical center in the Middle East. Sheba is the only medical center in Israel that combines an acute care hospital and a rehabilitation hospital on one campus, and it is at the forefront of medical treatments, patient care, research and education. As a university teaching hospital affiliated with the Sackler School of Medicine at Tel-Aviv University, it welcomes people from all over the world indiscriminately. In 2019, Newsweek magazine named Sheba one of the top ten hospitals in the world. To learn more, visit: eng.sheba.co.il.

Share article on social media or email:

CPPS Pilot Program

The CPPS course pilot group can truly be called innovators. We welcome these participants to the patient safety community and know they will change health care for the better.”

FORT WORTH, Texas (PRWEB)
September 10, 2019

Ten UNT Health Science Center students made history by completing the Certified Professional in Patient Safety (CPPS) pilot program, a unique collaboration between UNT Health Science Center, SaferCare Texas, and the Institute for Healthcare Improvement (IHI).

The CPPS credential distinguishes health care professionals who demonstrate competency in the following patient safety domains: culture, leadership, risks and solutions, measuring and improving performance, and systems thinking and design/human factors. The pilot is the first program nationally specifically offered to provide qualified medical students an opportunity to prepare for the CPPS certification exam.

“Ensuring future providers understand critical concepts related to patient safety is an essential part of their learning experience,” said Lillee Gelinas, MS, RN, CPPS, FAAN, Senior Fellow at SaferCare Texas, who led the CPPS review course pilot. “We chose to implement the CPPS pilot program to help qualified candidates prepare for the certification exam by reviewing the key domain content areas and test-taking strategies.”

IHI’s CPPS credential is the leading health care interprofessional certification specific to the field of safety. More than 3,000 professionals have earned the CPPS credential, representing all 50 states and 10 countries. Achieving certification demonstrates personal and professional commitment to the patients and families who trust providers and health care professionals to do no harm while compassionately providing evidence-based care.

“IHI’s mission is to improve health and health care worldwide, and the CPPS credential helps fulfill that mission by setting standards for the field,” said Patricia McGaffigan, RN, MS, CPPS, IHI’s Vice President of Patient Safety Programs and President of the Certification Board for Professionals in Patient Safety. “The CPPS course pilot group can truly be called innovators. We welcome these participants to the patient safety community and know they will change health care for the better.”

Sponsored by SaferCare Texas, the pilot was conducted with 10 Texas College of Osteopathic Medicine (TCOM) students who are members of the IHI Open School – Fort Worth Chapter. To qualify, participants met IHI’s CPPS requirements and SaferCare Texas’ criteria for selection into the course. The students received a scholarship from SaferCare Texas to cover the costs of the review course, practice exams, and the certification exam.

“With an estimated 440,000 deaths occurring every year from preventable errors, it is critical that future health care professionals, like myself, take patient safety seriously,” said Heather D. DeVille, MS, CPPS, OMS-II, TCOM student and IHI Open School Fort Worth Chapter President. “I’m looking forward to sharing the strategies and lessons learned throughout this course with my peers and future organizations.”

SaferCare Texas plans to expand this program into other colleges and schools across UNT Health Science Center’s campus. If you would like more information, please contact Katie Shanklin at katie.shanklin(at)unthsc(dot)edu.

About SaferCare Texas

A department within the UNT Health Science Center, SaferCare Texas was founded in response to the national challenge to improve patient safety and eliminate preventable harm. Through professional and community education, applied research, and quality improvement projects, SaferCare Texas identifies opportunities to eliminate medical errors and assure all patients receive the safest care. SaferCare Texas includes diverse health care and related institutions throughout the region, as well as fellows and scholars who represent a broad array of health care professionals, patients, and advocates. Learn more at Safercaretexas.org

About UNT Health Science Center

UNT Health Science Center is one of the nation’s premier graduate academic medical centers, with six schools that specialize in patient-centered education, research and health care. With a passion for teamwork and innovation, UNTHSC is driven to improve the human condition. For more information, visit https://www.unthsc.edu/

Share article on social media or email:

ATTORNEY JOHN Q. KELLY

“You are allowed to use reasonable force to protect yourself and your family from bodily harm,” Kelly commented.

GREENWICH, Conn. (PRWEB)
September 09, 2019

Connecticut banker Scott Hapgood is accused of manslaughter in connection with the death of hotel maintenance worker Kenny Mitchel. (Gavin Scott Hapgood v Regina in the Courts of Anguilla CLAIM No. AXAHCV 2019/0018) Hapgood has told authorities that Mitchel came to his hotel room door on April 13 at the Malliouhana An Auberge resort on the island of Anguilla, wielded a knife, tried to rob him, and threatened his daughter. Hapgood then used reasonable force to restrain him.

The ensuing confrontation and struggle left Mitchel dead and Hapgood bloodied and bruised. “You are allowed to use reasonable force to protect yourself and your family from bodily harm,” Kelly commented.

According to Kelly, there are three main issues that are going to prove important in the trial. One will be the autopsy, or what actually caused Mitchel’s death. The Fox News interview with Kelly (https://video.foxnews.com/v/6075825576001/#sp=show-clips), which aired on Aug. 22, 2019, reported that Hapgood’s attorney said toxicology results show Mitchel had cocaine and alcohol in his system at the time of death, which may have caused him to act in a “frenzied” manner or may have been a contributing factor in his death. (https://www.stamfordadvocate.com/local/article/Report-Man-allegedly-killed-by-Darien-man-had-14341909.php) Second, the processing of the crime scene will play an important role in the trial. Third, determining whether witness statements were written down properly or videotaped, signed, and otherwise recorded accurately.

When asked if he thinks Hapgood can receive a fair trial, Kelly said it is hard to tell that ahead of time. Factors which will affect the outcome include the judge assigned to the case, the way in which the jury deliberates and how the prosecutor presents his evidence. Kelly also noted that the media portrayal of the case and any possible bias can also impact the trial.

About Ivey, Barnum & O’Mara, LLC

Ivey, Barnum & O’Mara, LLC is a general practice law firm which was established in Greenwich, CT in 1950. It is the largest Greenwich-based law firm, with a fully staffed branch office in New Canaan, CT and satellite locations in New York.

The firm is dedicated to its clients and community and offers service in a wide range of practice areas including personal injury and wrongful death, residential and commercial real estate, trusts and estates, employment law, civil litigation, corporate and franchise matters. The firm employs the latest technologies to successfully achieve their clients’ objectives, whether personal, family or business.

To learn more, visit https://www.ibolaw.com/ or call 203-661-6000 to schedule a consultation.

Share article on social media or email: